News Digest / Ticker: PCSA

Ticker: PCSA

09:01am, Thursday, Aug 07, 2025

Processa Pharmaceuticals Reports Wider Losses, Focuses on Next-Gen Cancer Therapies Amid Financial Struggles

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) - Q2 2025 Financial Overview Processa Pharmaceuticals is navigating through key developments and challenges as it works on advancing its clinical-stage biopharmaceutical pipeline, particularly focusing on next-generation cancer therapies. Despite prog...